Mentioned On
Episode Mentions
Pharma and BioTech Daily · Jul 28, 2026
AstraZeneca's $80B Target Amid Setbacks? | Pharma and Biotech Daily
“Appointed Michael Severino as CEO; focusing on Duchenne muscular dystrophy therapies”
Antibody-Drug Conjugates (ADCs) in OncologyNon-Stimulant ADHD TherapeuticsDuchenne Muscular Dystrophy (DMD) Treatments
View Analysis